TENNESSEE MPJE EXAM 2024 WITH 100% CORRECT ANSWERS

The PARTIAL FILLING of a prescription for a controlled substance listed in "[Schedule II]" "for patients in a LTCF or patients with a medical diagnosis documenting a terminal illness" is permissible if the pharmacist is UNABLE to supply the full quantity called for in a WRITTEN OR EMERGENCY ORAL prescription and he makes a "notation of the quantity supplied" on which three (3) methods? - correct answer 1. the FACE of the written prescription, 2. WRITTEN RECORD of the emergency oral prescription, or 3. in the ELECTRONIC PRESCRIPTION RECORD If a pharmacy technician, an accidentally, mixes two bottles of Tylenol syrup with the SAME DRUG STRENGTH & the SAME MANUFACTURER but DIFFERENT "lot numbers" and "expiration dates", the resultant mixture should be classified as a(n): - correct answer Misbranded Schedule II controlled prescriptions for patients in a LTCF or patients with a medical diagnosis documenting a terminal illness are valid for a period not to exceed: - correct answer 60 days from the issue date The "remaining portion" of the PARTIAL FILLING for a controlled substance listed in "[Schedule II]" "for patients in a LTCF or patients with a medical diagnosis documenting a terminal illness" must be filled within how many hours? - correct answer within 72 hours of the FIRST partial filling What should the pharmacist do when the "remaining portion" of the PARTIAL FILLING for a controlled substance listed in "[Schedule II]" "for patients in a LTCF or patients with a medical diagnosis documenting a terminal illness" CANNOT be filled within the giving time frame period? - correct answer the pharmacist shall NOTIFY the prescribing individual practitioner No further quantity may be supplied beyond 72 hours WITHOUT a new prescription. What must the pharmacist do if there is any question whether a patient may be classified as having a terminal illness? - correct answer The pharmacist must contact the practitioner PRIOR to any filling/partially filling the prescription. Who has the responsibility to assure that the Controlled Substance is for a "terminally ill patient" in LTCF?